Boundless Bio, Inc. SEC filings BOLD

Boundless Bio, Inc. has 162 filings in SEC EDGAR's recent list, going back to Mar 12, 2020. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 28, 2026 (material agreement). The company's fiscal year ends on December 31.

Boundless Bio, Inc. SEC filings
Form Description Filed Period
4 Insider transaction Nov 5, 2026 Nov 3, 2026
4 Insider transaction Oct 29, 2026 Oct 27, 2026
4 Insider transaction Oct 26, 2026 Oct 22, 2026
4 Insider transaction Oct 20, 2026 Oct 16, 2026
4 Insider transaction Aug 28, 2026 Aug 26, 2026
SCHEDULE 13G Ownership over 5% (passive) Aug 27, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
4 Insider transaction Jul 21, 2026 Jul 17, 2026
4 Insider transaction Jul 16, 2026 Jul 14, 2026
4 Insider transaction Jul 13, 2026 Jul 9, 2026
4 Insider transaction Jul 8, 2026 Jul 6, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jul 6, 2026 Jul 1, 2026
4 Insider transaction Jul 2, 2026 Jun 30, 2026
SCHEDULE 13G Ownership over 5% (passive) Jun 29, 2026 —
4 Insider transaction Jun 29, 2026 Jun 25, 2026
3 Initial insider ownership Jun 29, 2026 Jun 25, 2026
4 Insider transaction Jun 15, 2026 Jun 15, 2026
4 Insider transaction Jun 15, 2026 Jun 15, 2026
4 Insider transaction Jun 15, 2026 Jun 15, 2026
4 Insider transaction Jun 15, 2026 Jun 15, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 5, 2026 —
4 Insider transaction Jan 26, 2026 Jan 23, 2026
4 Insider transaction Jan 26, 2026 Jan 23, 2026
4 Insider transaction Jan 26, 2026 Jan 23, 2026
4 Insider transaction Jan 26, 2026 Jan 23, 2026
4 Insider transaction Jan 26, 2026 Jan 23, 2026
SCHEDULE 13G Ownership over 5% (passive) Dec 4, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
4 Insider transaction Jun 23, 2025 Jun 23, 2025
4 Insider transaction Jun 23, 2025 Jun 23, 2025
4 Insider transaction Jun 23, 2025 Jun 23, 2025
4 Insider transaction Jun 23, 2025 Jun 23, 2025
4 Insider transaction Jun 23, 2025 Jun 23, 2025
4 Insider transaction Jun 23, 2025 Jun 23, 2025
4 Insider transaction Feb 3, 2025 Feb 3, 2025
3 Initial insider ownership Feb 3, 2025 Feb 3, 2025
4 Insider transaction Jan 23, 2025 Jan 22, 2025
4 Insider transaction Jan 23, 2025 Jan 22, 2025
4 Insider transaction Jan 23, 2025 Jan 22, 2025
4 Insider transaction Jan 23, 2025 Jan 22, 2025
SC 13D Ownership over 5% (active) Oct 29, 2024 —
3 Initial insider ownership Oct 15, 2024 Oct 11, 2024
4 Insider transaction Aug 20, 2024 Aug 19, 2024
4 Insider transaction Aug 20, 2024 Aug 19, 2024
4 Insider transaction Aug 20, 2024 Aug 19, 2024
4 Insider transaction Aug 20, 2024 Aug 19, 2024
4 Insider transaction Aug 20, 2024 Aug 19, 2024
4 Insider transaction Aug 20, 2024 Aug 19, 2024
4 Insider transaction Jun 20, 2024 Jun 20, 2024
SC 13G Ownership over 5% (passive) Apr 12, 2024 —
SC 13G Ownership over 5% (passive) Apr 12, 2024 —
SC 13G Ownership over 5% (passive) Apr 10, 2024 —
SC 13G Ownership over 5% (passive) Apr 9, 2024 —
4 Insider transaction Apr 4, 2024 Apr 2, 2024
4 Insider transaction Apr 4, 2024 Apr 2, 2024
4 Insider transaction Apr 4, 2024 Apr 2, 2024
4 Insider transaction Apr 4, 2024 Apr 2, 2024
4 Insider transaction Apr 4, 2024 Apr 2, 2024
4 Insider transaction Apr 2, 2024 Apr 2, 2024
4 Insider transaction Mar 29, 2024 Mar 27, 2024
4 Insider transaction Mar 29, 2024 Mar 27, 2024
4 Insider transaction Mar 29, 2024 Mar 27, 2024
4 Insider transaction Mar 29, 2024 Mar 27, 2024
4 Insider transaction Mar 29, 2024 Mar 27, 2024
4 Insider transaction Mar 29, 2024 Mar 27, 2024
4 Insider transaction Mar 29, 2024 Mar 27, 2024
4 Insider transaction Mar 29, 2024 Mar 27, 2024
4 Insider transaction Mar 29, 2024 Mar 27, 2024
4 Insider transaction Mar 29, 2024 Mar 27, 2024
4 Insider transaction Mar 29, 2024 Mar 27, 2024
4 Insider transaction Mar 29, 2024 Mar 27, 2024
3 Initial insider ownership Mar 27, 2024 Mar 27, 2024
3 Initial insider ownership Mar 27, 2024 Mar 27, 2024
3 Initial insider ownership Mar 27, 2024 Mar 27, 2024
3 Initial insider ownership Mar 27, 2024 Mar 27, 2024
3 Initial insider ownership Mar 27, 2024 Mar 27, 2024
3 Initial insider ownership Mar 27, 2024 Mar 27, 2024
3 Initial insider ownership Mar 27, 2024 Mar 27, 2024
3 Initial insider ownership Mar 27, 2024 Mar 27, 2024
3 Initial insider ownership Mar 27, 2024 Mar 27, 2024
3 Initial insider ownership Mar 27, 2024 Mar 27, 2024
3 Initial insider ownership Mar 27, 2024 Mar 27, 2024
3 Initial insider ownership Mar 27, 2024 Mar 27, 2024
3 Initial insider ownership Mar 27, 2024 Mar 27, 2024
3 Initial insider ownership Mar 27, 2024 Mar 27, 2024
3 Initial insider ownership Mar 27, 2024 Mar 27, 2024
3 Initial insider ownership Mar 27, 2024 Mar 27, 2024

Showing 90 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
BOLD (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
La Jolla, CA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1782303

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.